Could serum Raftlin and GPER-1levels be new biomarkers for early detection of non-small cell lung cancer?
Abstract Background Lung cancer is the leading cause of cancer-related deaths worldwide. Therefore, the search for new biomarkers continues in order to diagnose lung cancer at an early stage. In this study, we investigated blood levels of G-protein associated membrane estrogen receptor (GPER)-1 and...
Saved in:
| Main Authors: | Aykut Eliçora, Berrak Güven, Hüseyin Engin, Gokcen Tugba Çevik, Hüseyin Fatih Sezer |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-01-01
|
| Series: | Journal of Cardiothoracic Surgery |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13019-024-03296-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of the relationship between serum and humor aqueous raftlin (Rftn1) levels and diabetic retinopathy
by: Mesen Selma, et al.
Published: (2024-11-01) -
Antitumor Effects of Quercetin and Luteolin in A375 Cutaneous Melanoma Cell Line Are Mediated by Upregulation of P-ERK, c-Myc, and the Upstream GPER
by: Shaymaa A. Hussein, et al.
Published: (2025-03-01) -
Potential of Kesambi Active Compound (Schleichera oleosa) as Antagonist G-Protein Estrogen Receptor 1 (GPER1) by In Silico
by: Radita Intan Aisyah Pratiwi, et al.
Published: (2023-02-01) -
GPER1-mediated suppression of acute cellular rejection in murine cervical heart transplantation by estradiol
by: Yiwei Liu, et al.
Published: (2025-04-01) -
Decoding estrogen receptor and GPER biology: structural insights and therapeutic advances in ERα−positive breast cancer
by: Taniya Saha, et al.
Published: (2025-06-01)